SLXN MEXC RealStocks
Own real SLXN shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 22:12:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Silexion Therapeutics Corp. (SLXN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $2.70, with a market capitalization of $69.03K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.57 to $777.12. This page covers its latest market performance, valuation, price trends and company information.
$69.03K | |
$3.11 | |
$3.39 | |
$2.60 | |
$3.23 | |
69.95K | |
434.96K | |
-- | |
$777.12 | |
$2.57 | |
-- | |
-- |
Silexion Therapeutics Corp. (SLXN) is trading at $2.73 in after-hours trading as of 2026-11-12 22:11:00, up 1.26% ($0.03) from the regular-session close of $2.70.
After-hours trading shows how investors are pricing SLXN after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Silexion Therapeutics Corp. (SLXN) moved from $3.68 to $2.70, representing a decline of 26.80% ($0.99).
The stock traded between $2.57 and $3.89 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 55.41 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.0%
SLXN is currently trading at $2.70, placing it 0.0% of the way from its 52-week low of $2.57 to its 52-week high of $777.12. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS). Its proprietary technology is designed to prompt tumor cells to degrade the messenger RNA (mRNA) that bridges the oncogene and the cellular protein synthesis machinery, utilizing small interfering RNA (siRNA) constructs that are chemically modified to enhance stability and cellular uptake while maintaining biological activity that interferes with the mRNA function. Its product candidate, SIL204, is a second-generation siRNA engineered to suppress the production of mutated KRAS proteins.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 13 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Silexion Therapeutics Corp.
Stock Split | |
|---|---|
| Split Date | Nov 11, 2026 |
| Split Ratio | 1-for-24 |
Eligible investors can buy real shares of Silexion Therapeutics Corp. (SLXN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SLXN, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SLXN shares and USD.
SLXN Shares to USD
1.00 SLXN shares = 2.695 USD
Calculations are estimates based on the latest available price and are for reference only.